Experiments conducted showed that this drug successfully prevented severe allergic reactions in 95% of mice with peanut allergies. The study, published in the journal “Science,” focused on the role of the gene “DBP1,” which controls the production of inflammatory materials called leukotrienes in the intestine, contributing to fatal anaphylaxis. Thanks to the ability of “Zileuton” to inhibit these substances, it is considered a promising candidate for preventing food allergies. This discovery is a significant step, especially since current treatment options for food allergies are limited and not suitable for everyone, making “Zileuton” a potential preventive option in the future.
-
Latest news
Trump and Putin to Meet in Alaska on August 1510.08.2025
-
World
Arab Military Spending vs. Israel 202517.09.2025
-
Latest news
UAE’s Historic Launch: Arab Satellite 81311.12.2025
